Emed Healthtech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 5 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 91.83%
(FY 2022)
- Profit -3.38%
(FY 2022)
- Ebitda 90.06%
(FY 2022)
- Net Worth 213.16%
(FY 2022)
- Total Assets 240.76%
(FY 2022)
About Emed Healthtech
The Corporate was formerly known as Emed Pharmatech Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Salimmd Chauhan, Aabid Ali, and Ahemadabbas Balospura serve as directors at the Company.
- CIN/LLPIN
U74999GJ2019PTC129758
- Company No.
333749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Emed Healthtech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Salimmd Chauhan  | Director | 08-Oct-2021 | Current |
| Aabid Ali | Director | 08-Oct-2021 | Current |
| Ahemadabbas Balospura | Director | 28-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Emed Healthtech.
Emed Healthtech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 91.83% increase. The company also saw a slight decrease in profitability, with a 3.38% decrease in profit. The company's net worth Soared by an impressive increase of 213.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emed Healthtech?
In 2022, Emed Healthtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pyxus Pharmaceuticals Private LimitedActive 6 years 4 monthsAhemadabbas Balospura is a mutual person
- Britanica Medicines & Medical Equipment Private LimitedActive 2 years 2 months
Ahemadabbas Balospura is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Emed Healthtech?
Emed Healthtech has a workforce of 7 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emed Healthtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emed Healthtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
